Decadron and Bedridden - a phase IV clinical study of FDA data

Summary:

Bedridden is reported as a side effect among people who take Decadron (dexamethasone), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lovenox, and have Osteoporosis.

The phase IV clinical study analyzes which people have Bedridden when taking Decadron. It is created by eHealthMe based on reports of 46,837 people who have side effects when taking Decadron from the FDA, and is updated regularly.

What is Decadron?

Decadron has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 47,210 Decadron users. Check the latest studies of Decadron.

What is Bedridden?

Bedridden is found to be associated with 882 drugs and 1,104 conditions by eHealthMe. Check the latest studies of Bedridden.

On Jul, 15, 2026

46,837 people reported to have side effects when taking Decadron.
Among them, 61 people (0.13%) have Bedridden.

Among these 61 people:

How long have people been on Decadron when they have Bedridden? *

What is the gender of people who have Bedridden when taking Decadron? *

female: 40 %
male: 60 %

What is the age of people who have Bedridden when taking Decadron? *

What are other drugs people take besides Decadron? *

What are other side effects people have besides Bedridden? *

Pain: 39 people, 63.93%
Depression: 33 people, 54.10%
Fall: 31 people, 50.82%
High Blood Pressure: 31 people, 50.82%
Back Pain: 30 people, 49.18%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 29 people, 47.54%
Weight Decreased: 28 people, 45.90%
Bone Disorder: 27 people, 44.26%
Anaemia (lack of blood): 26 people, 42.62%
Abdominal Pain: 26 people, 42.62%

What are the existing conditions these people have? *

Prostate Cancer: 16 people, 26.23%
Osteoporosis (bones weak and more likely to break): 16 people, 26.23%
High Blood Cholesterol: 11 people, 18.03%
Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 6 people, 9.84%
Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 2 people, 3.28%
Rashes (redness): 2 people, 3.28%
Pain: 2 people, 3.28%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 3.28%
Delayed Effects Of Radiation: 2 people, 3.28%
Cervix Carcinoma (cancer of cervix): 2 people, 3.28%

* Approximation only. Some reports may have incomplete information.

Do you take Decadron and have Bedridden?

- Check whether Bedridden is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Decadron:

Decadron (47,210 reports)

Bedridden treatments and more:

Bedridden (14,887 reports)

Browse all side effects of Decadron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bedridden:

Bedridden (882 drugs)

Browse all the conditions that are associated with Bedridden:

Bedridden (1,104 conditions)

Related publications that referenced our studies

Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .
Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on dexamethasone (the active ingredients of Decadron) and Decadron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.